Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKR

Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKRO) Target Price to $56.00

Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKRO) Target Price to $56.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Wellington , New Zealand General , New Zealand , United States , America , Catriona Yale , Jonathan Young , Akero Therapeutics Inc , Redmile Group , Securities Exchange Commission , Lord Abbett , Akero Therapeutics Company Profile , Canaccord Genuity Group , Vanguard Group Inc , Wellington Management Group , Akero Therapeutics , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Management Group , Akero Therapeutics Daily ,